AstraZeneca PLC
AZN · NASDAQ
9/30/2025 | 6/30/2025 | 3/30/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $2,533 | $3,127 | $2,916 | $1,666 |
| Dep. & Amort. | $1,549 | $1,389 | $1,284 | $714 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $835 | -$345 | -$426 | -$350 |
| Other Non-Cash | $217 | -$785 | -$61 | $877 |
| Operating Cash Flow | $5,134 | $3,386 | $3,713 | $2,907 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$686 | -$659 | -$429 | -$708 |
| Net Acquisitions | -$328 | -$267 | -$362 | -$274 |
| Inv. Purchases | $0 | -$188 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $114 | $0 | -$32 |
| Other Inv. Act. | -$987 | -$1,108 | -$462 | -$167 |
| Investing Cash Flow | -$2,001 | -$2,108 | -$1,253 | -$1,181 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$93 | $632 | $1,095 | -$608 |
| Stock Issued | $0 | $1 | -$478 | $23 |
| Stock Repurch. | -$19 | $0 | $0 | $0 |
| Dividends Paid | -$1,611 | -$10 | -$3,347 | -$3 |
| Other Fin. Act. | -$350 | -$105 | $23 | -$83 |
| Financing Cash Flow | -$2,073 | $518 | -$2,707 | -$671 |
| Forex Effect | -$12 | $29 | $25 | -$61 |
| Net Chg. in Cash | $1,048 | $1,825 | -$222 | $994 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $7,032 | $5,207 | $5,429 | $4,435 |
| End Cash | $8,080 | $7,032 | $5,207 | $5,429 |
| Free Cash Flow | $4,448 | $1,463 | $3,284 | $1,952 |